FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

Narrative

No narrative content found in resource

Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1170.4",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2024-09-06T09:18:04.000-04:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "Acumen OP Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-keyWord",
      "valueString": "STEMI"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-04-16"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2021-10-07"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1170.4",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1170.4"
    }
  ],
  "version": "20211007",
  "name": "ThrombolyticMedications",
  "title": "Thrombolytic medications",
  "status": "active",
  "experimental": false,
  "date": "2021-10-07T01:00:28-04:00",
  "publisher": "Acumen OP Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for thrombolytic medications used for treatment of ST-segment elevation myocardial infaction (STEMI).),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes RXNORM codes that represent ingredients in thrombolytic medications for STEMI treatment.),(Exclusion Criteria: No exclusions)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "10106",
            "display": "streptokinase"
          },
          {
            "code": "11055",
            "display": "urokinase"
          },
          {
            "code": "259280",
            "display": "tenecteplase"
          },
          {
            "code": "40028",
            "display": "anistreplase"
          },
          {
            "code": "76895",
            "display": "reteplase"
          },
          {
            "code": "8410",
            "display": "alteplase"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:51ad26e5-78b9-4a4f-be58-ace5708ff0fe",
    "timestamp": "2025-05-23T19:05:45-04:00",
    "total": 6,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "10106",
        "display": "streptokinase"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "11055",
        "display": "urokinase"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "259280",
        "display": "tenecteplase"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "40028",
        "display": "anistreplase"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "76895",
        "display": "reteplase"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "8410",
        "display": "alteplase"
      }
    ]
  }
}